Abstract
Hypermethylation of CpG islands in gene promoter regions has been shown to be a predictive biomarker for certain diseases. Most current methods for methylation profiling are not well-suited for clinical analysis. Here, we report the development of an inexpensive device and an epigenotyping assay with a format conducive to multiplexed analysis.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Animals
-
CpG Islands*
-
DNA Methylation*
-
DNA-Binding Proteins / analysis
-
DNA-Binding Proteins / metabolism*
-
Equipment Design
-
Humans
-
Mice
-
Microfluidic Analytical Techniques / instrumentation*
-
Nucleic Acid Hybridization
-
Promoter Regions, Genetic
Substances
-
DNA-Binding Proteins
-
Mbd1 protein, mouse